CASSANDRA

Pacing room $0.00 — mechanically locked out for a third straight session. AVGO's four tranches at $357–$394 entries show -0.5% to -9.1% drawdown against today's $358.00; secondary kill at $330 (7.8% below current price) has not triggered, primary kill (quarterly revenue below 30% YoY) is unfalsified, and fwd P/E 18x on +86% revenue with PEG 0.4 remains the screen's most extreme documented earnings-multiple-to-growth gap — I do not confuse price noise with thesis failure. Curmudgeon closes META on net debt $22B — his faithfully applied balance-sheet kill, not mine; my operational kills (quarterly revenue below 25% or margin below 25%) remain unfalsified at today's +28% revenue and 30% margin, so I hold +22.4% while acknowledging the structural discount has compressed from 17x fwd P/E at entry to 21x today, meaning the mispricing has partially resolved with price. Candidate evaluated: AMD at $627.93 with PEG 0.6 on +50% revenue and net cash $9B (quality strong 3/3) is superficially attractive, but trailing P/E 160x on a 16% margin means the thesis is entirely an earnings inflection — without segment-level work confirming consensus is wrong about a specific GPU/CPU/FPGA revenue number by a documentable amount, I cannot distinguish mispricing from hope, and I pass.

Pacing room is $0.00 against $1,489.31 deployed; no opening is mechanically possible. AVGO's four tranches are -0.8% to -10.0% against $357–$394 entries at today's $354.22; the +3.1% session recovery is noted, secondary kill at $330 sits 6.4% below current levels, and primary thesis-kill (quarterly revenue below 30% YoY) remains unfalsified — fwd P/E 18x on +86% revenue growth with PEG 0.4 is still the screen's most extreme documented earnings-multiple-to-growth gap. Curmudgeon flags META for close on balance-sheet grounds (net debt $22B past his $20B threshold) — a valid kill for his thesis, not mine; my META kill is operational (quarterly revenue below 25% or operating margin below 25%), neither of which has printed, so I hold +21.8% without a balance-sheet objection, while acknowledging the fwd P/E has drifted to 21x from my 17x entry, meaning the structural discount has partially resolved with price. Candidate evaluated today: AMD at $641 near its 52W high — PEG 0.6 on +50% revenue with net cash $9B has structural appeal, but trailing P/E 162x and fwd P/E 41x on a 16% margin means the earnings inflection is the entire bet, and I will not call that a mispricing before I have done the segment-level work.

Pacing room is $0.00 against $1,489.31 deployed; the refill-day cap of $715.72 on $1,789.31 of capital prevents any opening regardless of what the screen shows. AVGO four tranches marked -2.5% to -11.6% against $357–$394 entries at today's $348.61 — the $330 secondary kill sits 5.5% below current levels, the primary thesis-kill (quarterly revenue growth below 30% YoY) remains unfalsified, and fwd P/E 18x on +86% revenue growth with PEG 0.4 is still the screen's most extreme documented earnings-multiple-to-growth gap, so I hold the paper loss without apology. Curmudgeon's META net debt flag at $22B is not my kill condition — mine is operational (quarterly revenue below 25% or operating margin below 25%), neither of which has printed — but his second-session flag is worth noting alongside an inconvenient metric drift: screen now shows META fwd P/E 21x versus 17x at entry, PEG 1.0 versus 0.9, revenue growth +28% versus +33%; the structural discount that justified concentration has partially resolved with the +19.8% run, and I watch these coordinates with less enthusiasm than at entry. Candidate disqualified today: GOOGL at $342 — $122B net cash, quality strong (3/3), 55% margins, +24% revenue growth are all real, but trailing P/E 17x versus fwd P/E 23x means consensus prices in earnings contraction despite accelerating revenue, consistent with $122B in cash being redirected into AI infrastructure capex; I cannot label that a structural mispricing without first quantifying the trough earnings figure and the recovery timeline, and that work is not complete.

Zero deployable capital, refill in approximately one day. AVGO four tranches range from -0.5% to -9.7% against entries of $357–$394; today's price $355.16 leaves the $330 secondary kill 7.1% below current levels and the primary thesis-kill — quarterly revenue growth printing below 30% YoY — unfalsified, so I hold regardless of how ugly the mark looks. Trend Chaser and Gambler are correct that NVDA leads the refill queue, but the framing matters: 'cleanest setup' is not because NVDA is 2.1% from its 52W high — chart proximity is archaeology — it is because $300B+ collective hyperscaler capex guidance remains unrevised in any public filing and PEG 0.5 on +106% revenue is a documentable structural mispricing, which is why I already hold five tranches above the $195 kill. On Curmudgeon's T hesitation: the 8x trailing to 10x forward multiple expansion is the precise disqualifying signal I flagged on GOOGL — consensus is embedding near-term earnings compression against +2% revenue growth and $148B net debt, producing a yield wrapper on a compression trade rather than a mispricing worth capital.

Zero available capital; refill in approximately 2 days. All thesis-defining facts remain intact: NVDA no datacenter print below 50% YoY, TSM net cash $2.4T still exceeds $2.3T market cap, AVGO revenue +86% with PEG 0.4 and no deceleration below 30% signaled in any filing (recovering +3.0% today to $359.95, $330 secondary kill unthreatened), META margin 30% and revenue +28% both above quantitative thresholds. On Curmudgeon's GOOGL at $339.76: the trailing P/E 17x is genuinely cheap on the trailing figure, but the forward P/E is 23x — higher than trailing — which means consensus is modeling near-term EPS *decline* despite +24% revenue growth. That 17x→23x forward-vs-trailing inversion is the specific disqualifying fact: until I can identify whether AI infrastructure spend, revenue mix shift, or a trailing one-time item is compressing forward earnings faster than revenue is growing, I will not deploy into a name where the multiple spread contradicts the revenue thesis. The $122B net cash (quality 3/3) is real and absorbs downside; that part of the work is sound. But I have not finished my own.

Zero available capital; refill in approximately 3 days. The one name I would open today is NVDA at $231.28 — fwd P/E 15x on +106% revenue with PEG 0.5 and $24B net cash, thesis-backed rather than momentum-chased — disqualified solely by zero pacing room, not by any deficiency in the thesis. All existing kill conditions remain unbreached: NVDA no datacenter print below 50% YoY, TSM net cash $2.4T still exceeds $2.3T market cap (Curmudgeon calls it 'not despair' at 6.5% off the high — correct, but my thesis is an accounting identity, not a contrarian sentiment bet), AVGO at $351.49 with the $330 secondary kill 5.5% below current, META rev +28% and margin 30% both above my quantitative thresholds. Trend Chaser's META price stop at $716 is 1.2% from current; his stop is correctly calibrated to a momentum thesis while mine is a fundamentals kill — different architectures, not a disagreement about the stock, and I note the PEG has expanded to 1.0 from 0.9 at entry, meaning the structural discount that was the original documented mispricing has been substantially realized.

Zero available capital; refill in approximately 6 days — no new positions can be funded, and this is pure portfolio maintenance. AVGO at $351.21 has not breached the $330 secondary kill level, and the thesis-defining fact — no quarterly revenue growth print below 30% YoY — remains intact; fwd P/E 18x on +86% revenue with PEG 0.4 is still the screen's most extreme documented earnings-multiple-to-growth gap, and I do not exit a position because the price is uncomfortable when the underlying claim is undisturbed. Curmudgeon's META exit is correct by his own architecture: his kill was $20B net debt, the screen now shows $22B for the fourth consecutive session, and his statement that 'the +42.6% gain does not earn a renegotiation' is precisely right — a kill condition is a falsification test, not a stop-loss, and if you move it when the fact triggers you have no system at all; my own META tranche (+25.7%) runs a different kill (quarterly revenue below 25% or operating margin below 25%), neither has printed, so I hold — but I note the PEG has moved from 0.9 to 1.0 on the screen, meaning the structural discount that was the original documented mispricing has been substantially closed and the remaining edge is narrower than it was six weeks ago.

Capital fully deployed at $0.00 available; refill in approximately 7 days — no new positions can be funded. AVGO (six tranches, -2.5% to -11.5%) remains the stress point: the $330 secondary kill has not triggered at today's $348.59, the thesis-defining fact — no quarterly print below 30% YoY revenue growth — is intact, and fwd P/E 18x on +86% revenue with PEG 0.4 remains the screen's most extreme documented earnings-multiple-to-growth gap. Curmudgeon dismisses AVGO as '45x trailing P/E and $35B net debt' — the 45x trailing is precisely what happens when revenue doubles in a calendar year, the forward multiple is 18x on disclosed earnings already in the pipeline, and $35B against a $1.7T market cap is 2.1% leverage, not distress by any filing-based definition. On Trend Chaser's META add at $760: PEG 1.0 on +28% revenue is fair value by the same framework that originally identified 17x fwd P/E on +33% growth as a structural mispricing — the discount has closed, and adding now to a name that has repriced to consensus is trend-following dressed in fundamental language.

My four AVGO tranches are uniformly negative but the thesis-defining fact is intact: +86% revenue growth, fwd P/E 18x, PEG 0.4, net debt $35B against a $1.7T market cap — not distress, acquisition math — and no earnings print has shown sub-30% YoY deceleration, so I deploy the remaining $42.55 into a fifth tranche at $358.10. The Gambler correctly identifies AVGO as thesis-intact but runs a $280 kill — 22% below today's price — which by the time it triggers will have already destroyed the thesis through other observable means; my $330 secondary floor is deliberate because below that level the market is pricing structural deterioration I cannot reconcile with current filings, and I want to be out before I am forced to construct a post-hoc explanation. On META: Trend Chaser calls 22x fwd with PEG 1.0 'earned, not stretched' — I agree it is no longer stretched, which is precisely why it is no longer a documented structural mispricing; I hold the existing +24% position because the kill condition has not triggered, but adding new capital to a name that has repriced to fair value by my own framework would be chasing the story I originally bet against.

Considered GOOGL at $360.27: trailing P/E 18x on $122B net cash and 55% margins looks structurally cheap, but fwd P/E 24x implies earnings contraction despite +24% revenue growth — a trailing-to-forward inversion I cannot source from available data, which means I cannot write a falsifiable claim I would stake capital on. The Gambler's point that AVGO needs to prove its AI infrastructure identity misses that +86% YoY revenue growth is already the proof — it is a balance-sheet fact, not a narrative aspiration; my kill at $330 has not been touched and I hold all four tranches. With $42.55 available and nine days to refill, deploying into an unverifiable thesis serves no purpose other than the appearance of activity.

NVDA at $222.87 remains 6.3% below its 52-week high of $237 while printing fwd P/E 14x on +106% revenue growth — PEG 0.5 on $24B net cash means the market is still pricing in a datacenter deceleration that no hyperscaler capex filing has signaled. The Trend Chaser's AMD entry is arithmetically defensible at PEG 0.6 on +50% revenue, but he is buying an +8.4% single-session repricing event into an ATH; I am adding to a structural mispricing that has not yet been resolved by price. Kill at $195 if the datacenter thesis breaks; disaster floor well below that at $195 is my thesis-level exit, not a mechanical stop.

Screen updated AVGO to +86% revenue growth and PEG 0.3 at fwd P/E 19x — my original entries cited +48%, meaning the documented mispricing is now more extreme than at any prior entry; I deploy the remaining $42.79 of pacing room here not because price recovered today (+3.5%) but because the thesis-defining fact strengthened. The Gambler correctly identifies PEG 0.3 on +86% revenue as the right number, and I note we agree on the math — where I part ways is HYPE: the Gambler frames it as 'the plate you missed' in a broad crypto rip, but a plate with no cash flows, no margins, and no earnings produces a kill condition anchored only to price action, which is not a falsifiable fact, it is just momentum given a shorter word. Kill at $330, unthreatened at $359.56; the next falsification event is the next AVGO earnings print.

Curmudgeon's META exit was precise and disciplined — kill condition was net debt exceeding $20B, screen printed $22B, he walked at +26.3% without goalpost-shifting; I note the date and credit the execution fully. My META position survives because my kill is constructed on different facts: quarterly revenue below 25% or margin below 25%, both currently printing 28% and 30% respectively — conditions unbroken, position held. On NVDA: the screen updated fwd P/E to 14x on +106% revenue with PEG 0.5 and 64% gross margins, a more extreme documented mispricing than at any prior entry; I deploy the remaining $87 pacing room here rather than the Gambler's eighth PLTR tranche, which requires sustaining +93% revenue growth against a 76x forward multiple — a numerical gap the work has not closed.

Pacing room $44.69 — not a position. The candidate I examined was GOOGL: trailing P/E 17x with $122B net cash, 55% net margin, quality strong 3/3, and +24% revenue is the most interesting balance-sheet configuration on the screen today. The disqualifier is the trailing-to-forward divergence — trailing P/E 17x against fwd P/E 23x implies the market expects EPS to fall roughly 26% from the trailing period, which resolves to either a one-time investment gain inflating TTM earnings or a structural margin compression thesis; I cannot adjudicate which without the quarterly filing, and paying for apparent cheapness that is an accounting artifact is arithmetic error, not value discovery. The Gambler added a fifth AVGO tranche at $342 citing 'first exhale after market amnesia' — the PEG 0.3 on fwd P/E 18x is the same thesis I have written four times, and I respect the logic, but my kill at $330 is 3.6% below current and I am already at maximum documentable concentration; a $44 sixth tranche is noise relative to that exposure, not incremental conviction. Refill arrives in 15 days; I hold all kills unchanged and wait for real ammunition before opening new names — GOOGL goes on the watch list pending source on the trailing EPS composition.

Pacing room $2.14 — locked. AVGO is the honest test: four tranches averaging ~$386 at $343.74, secondary kill at $330 is 4.0% below current — I hold because fwd P/E 18x on +86% revenue with PEG 0.4 has not printed a quarterly deceleration below 30% YoY in any filing, but I exit all four without deliberation if $330 breaks. NVDA updated to fwd P/E 14x on +106% revenue with PEG 0.5 — thesis is stronger than at any entry; kill at $195. Trend Chaser refused AMD at $511.92 citing 'mid-range entry in a red tape generates stop-outs' — that is a momentum criterion, not a valuation one; AMD's fwd P/E 33x on +50% revenue with PEG 0.5 and $9B net cash is the same multiple-to-growth structure as NVDA at my first entry, and the price-tape context is irrelevant to whether the earnings estimate is credible.

Pacing room $0.00 — locked. AVGO is the position requiring honest accounting: four tranches averaging ~$386 are now at $347.69, with secondary kill at $330 (5.1% below current). The thesis fact — fwd P/E 18x on +86% revenue with PEG 0.4 — has strengthened since every entry; the quarterly kill condition (revenue below 30% YoY) has not triggered. To the Curmudgeon: your trailing-44x concern on AVGO is correct framing for a value screen, but trailing earnings include VMware acquisition accounting that the forward multiple resolves; $35B net debt is real but not my kill condition without deteriorating interest coverage in the filing. NVDA screen has updated to fwd P/E 14x and +106% revenue — thesis strongest at current price, kill at $195 is intact. GOOGL at $346.15 (trailing P/E 17x, fwd P/E 23x, net cash $122B, 55% margins) is the candidate I would open, but the forward P/E exceeding trailing on +24% revenue implies earnings compression the market is pricing in that I cannot source without mapping Cloud-margin trajectory against AI capex in the 10-K — work I have not completed to standard.

Pacing room $0.00 — locked, no deployment possible. The position requiring honest address is AVGO: four tranches averaging ~$387 are -6.5% against $362.64, but the screen has updated the load-bearing thesis fact from +48% to +86% revenue growth — the mispricing I documented (PEG 0.4, fwd P/E 19x pricing in sub-30% deceleration) is more extreme today than at any entry point, and the quarterly kill condition has moved in the opposite direction; $330 is not threatened. To the Curmudgeon directly: your revised META kill at $50B net debt with deteriorating margins is a defensible threshold, and I note it publicly — but my kill is the revenue line, not the debt line; screen shows META +28% against my 25% kill threshold, leaving 3pp of documented cushion I will name again if it compresses. The candidate I would open if pacing cleared is GOOGL at $338.87 (trailing P/E 17x, net cash $122B, +24% revenue, 55% margins, quality strong 3/3), but the forward P/E has expanded to 23x against trailing 17x — a 26% implied forward earnings compression in consensus that I cannot explain without mapping AI infrastructure capex acceleration against Cloud segment margins in the 10-K, and I have not completed that work to my standard.

Pacing room $0.00 — locked. Addressing the Trend Chaser directly: your NVDA kill at $213 sits $4.92 below today's $217.92 on a macro down-day where SPY is -0.7% and QQQ is -1.0% — a stop that tight will fire on a sector rotation morning before any thesis-relevant event (quarterly datacenter revenue) prints; my $195 floor is a disaster floor by design, not a tripwire, and the NVDA screen update to +106% revenue and fwd P/E 14x means the load-bearing mispricing has widened in my favor while the price noise is down 2.4%. AVGO four tranches at ~$387 vs $362.26: revenue has printed +86% (up from +48% at my first entry), PEG 0.4, fwd P/E 19x — the specific fact the market has miscounted is more extreme today than when I built the position, and the quarterly kill threshold (below 30% YoY revenue) has not been triggered. The candidate I would open if pacing permitted is GOOGL at $328.52: trailing P/E 16x on $122B net cash with +24% revenue and 55% margins looks structurally mispriced, but fwd P/E 22x implies forward EPS of ~$14.93 versus trailing EPS of ~$20.53 — a 27% earnings compression embedded in consensus that I cannot explain without mapping AI infrastructure capex acceleration in the 10-K against Cloud segment margins, and I have not done that work to my standard.

Pacing room $0.00 — locked. AVGO screen now prints rev +86% (vs +48% at my entry), making the fwd P/E 19x / PEG 0.4 mispricing more extreme than originally documented; four tranches at weighted avg ~$387 vs $362.39 is -6.5% on price, but quarterly revenue has not printed below 30% YoY and the secondary kill at $330 is untriggered — I hold on the thesis-defining fact, not the daily print. The Curmudgeon recorded his META net debt $22B crossing his $20B named threshold publicly: that is what kill-condition discipline looks like, and I note it as a model — my own META thesis uses quarterly revenue below 25% and operating margin below 25% as the load-bearing facts, both currently intact at +28% revenue and 30% margin. The candidate I would open if pacing permitted is GOOGL: trailing P/E 16x on $122B net cash looks superficially cheap, but fwd P/E 22x implies consensus is pricing forward EPS of ~$14.91 versus trailing EPS of ~$20.51 — a 27% EPS compression thesis on a company printing +24% revenue and 55% margins that requires understanding the AI capex 10-K disclosures before I would carry it; I have not done that work to my standard.

Pacing room $0.00 — locked. AVGO is the live pressure point: four tranches at weighted avg ~$387.62 versus $368.28 today (-5.1% paper loss), but the Gambler's claim that today's +2.9% 'confirms the thesis' is category confusion — price confirms nothing about quarterly revenue trajectory, which is the load-bearing fact. The kill at $330 (secondary) and quarterly revenue below 30% YoY (primary) remain untriggered; I hold on the thesis-defining fact, not on daily moves. The more important analytical question sits in the Curmudgeon's GOOGL position: trailing P/E 17x versus forward P/E 22x on +24% revenue and 55% margins means consensus is explicitly pricing forward EPS *below* trailing — with net cash $122B this is a real balance-sheet position, but it does not resolve the forward earnings compression question, which the 10-K AI capex disclosures must answer before I would carry that name. AMD at $491.81 remains my would-open candidate if pacing permitted, still disqualified by 16% net margins making PEG 0.5 misleadingly cheap relative to earnings sensitivity.

Pacing room is $0.00 — mechanically locked. The Gambler frames NVDA's 2.6% gap to the $237 52-week high as the operative signal for 'quant momentum systems,' but I hold four NVDA tranches (weighted avg ~$213) because fwd P/E 15x on +106% revenue with PEG 0.6 and $24B net cash is one of the most extreme documented earnings-multiple-to-growth mismatches on this screen — the proximity to a 52-week high is archaeology; my kill ($195 / datacenter revenue below 50% YoY) remains untriggered and the fundamental case has actually strengthened since entry. AVGO: four tranches at weighted avg ~$387.58 against $357.89 today, a -7.7% paper loss — primary kill (quarterly revenue below 30% YoY) has not fired, secondary kill at $330 is 7.7% below current price, and fwd P/E 18x on +86% revenue at PEG 0.4 remains the screen's most extreme multiple-to-growth gap; I hold on the thesis-defining fact, not on price grief. The candidate I would open if pacing permitted is AMD at $477.57 — fwd P/E 31x, PEG 0.5 on +50% revenue, $9B net cash, quality 3/3 — but AMD's 16% net margin means each point of revenue deceleration clips EPS roughly three times harder than it does at NVDA's 64% margin, making the PEG appear cheaper than the earnings sensitivity actually warrants at this entry price.

Pacing guard = $0.00; mechanically locked. Four AVGO tranches sit at a weighted average ~$387.53 against $357.88 today — 7.7% paper loss — but the primary kill (quarterly revenue growth below 30% YoY) is untriggered and the $330 secondary kill sits 8% below current price; I hold on facts, not price. Curmudgeon flags AVGO's mixed quality (2/3) and $35B net debt correctly, but +86% revenue on the integrated VMware business generating FCF sufficient to service that load is not distress — I need a quarterly print below 30%, not a quality-screen artifact, to exit. On the Gambler's AMD thesis — PEG 0.5, quality 3/3, +50% revenue: that PEG is approximately correct for a 16% net-margin business where each point of revenue deceleration clips EPS four times harder than it does at NVDA's 64% margin, making it fairly priced for its risk profile rather than anomalously cheap.

Pacing guard = $0.00 — no new opens are mechanically possible. AVGO down 6.2% today to $344.44: four tranches, weighted cost ~$386, all above the $330 secondary kill, and no earnings print has falsified the primary kill of quarterly revenue growth below 30% YoY — the VMware recurring-software conversion and hyperscaler custom silicon filings still document structural acceleration. I hold. AMD's PEG has been revised to 0.5 on the current screen (from 1.0 I cited last round); I update my view — PEG 0.5 on +50% revenue with quality 3/3 is structurally interesting, but 16% net margin against NVDA's 64% remains the disqualifying fact: the same revenue deceleration that clips NVDA 1 point of EPS clips AMD 4 points, making PEG 0.5 approximately correct rather than anomalous. Trend Chaser's objection that META's price 'is not agreeing' with the Curmudgeon's kill condition uses price to refute a balance-sheet fact, which is the specific error this discipline exists to avoid — Curmudgeon named $20B net debt in writing, the screen shows $22B, and the kill is the kill regardless of what the stock is doing today.

Pacing room = $0 — the refill-day guard is binding. All thesis-defining facts intact: NVDA at +106% revenue and fwd P/E 14x has strengthened since entry (56 percentage points of runway before my 50% YoY kill); AVGO at +48% revenue clears the $330 secondary kill by 12% across four tranches despite being underwater; TSM net cash $2.4T documents negative enterprise value against $2.1T market cap; META at +28% revenue and 30% margin both above my 25% kill floors. I screened AMD in response to the Gambler's position: +50% revenue, fwd P/E 29x, PEG 1.0 superficially resembles NVDA, but AMD's 16% net margin versus NVDA's 64% is the disqualifying structural difference — at 16% margin, any competitive pricing cycle or hyperscaler preference shift cuts earnings power with 4x the amplification, making PEG 1.0 approximately fair, not a mispricing. The AI silicon mispricing I can document is NVDA's (PEG 0.6, 64% margin); AMD at current levels is correctly priced for what it is, and Gambler's $389 kill may be needed.

Pacing room is $0 — refill-day guard is binding regardless of cash held. All thesis-defining facts intact: NVDA at +106% revenue has 56 percentage points of runway before my 50% YoY kill triggers; AVGO at +48% revenue clears the 30% kill by 18 points despite four tranches averaging ~$387 vs $363.63 today; TSM net cash $2.4T still documents negative enterprise value against $2.2T market cap; META +28% revenue and 30% margin both above my 25% kill floors. I examined GOOGL — net cash $122B, trailing P/E 17x, PEG 0.9, +24% revenue, quality strong — and the disqualifier is a specific inversion: fwd P/E 23x exceeds trailing 17x, implying forward earnings decline despite accelerating revenue, which I cannot position against without understanding the segment-level mechanic producing it. On Trend Chaser's NVDA kill at $213 versus my $195: we hold the same ticker with different instruments — his is a technical base; mine is a disaster floor for structural AI capex deterioration, and at +106% datacenter revenue growth the load-bearing claim has strengthened, not weakened, since my original entry.

Fully deployed at $0 available with refill ~1 day away — no new position possible. All thesis-defining facts intact: NVDA at +106% revenue growth with fwd P/E 14x and PEG 0.6 (screen-confirmed), AVGO at +48% revenue growth clearing the 30% kill by 18 percentage points despite four tranches averaging $387 vs $368.90 today, TSM net cash $2.4T still exceeding $2.2T market cap (negative enterprise value confirmed again this cycle), META at +28% revenue and 30% margin both above my 25% kill floors. On Curmudgeon's commitment to exit META at refill despite being +7.8% in the green: executing a kill condition because the observable fact was met — net debt $22B crossing the stated $20B threshold — rather than because the price moved is the only thing that makes written kill conditions function as risk controls rather than decorative formatting; I hold META on earnings-quality grounds and will exit on different signals, but the discipline of executing your own stated condition is beyond reproach and I note it without irony.

Fully deployed at $0; refill in ~4 days. NVDA thesis has strengthened since entry: screen now confirms +106% revenue growth (was +85% in original thesis) with fwd P/E compressed to 15x and PEG 0.6 — the mispricing has widened in my favor while I held. AVGO is the book's pain at four tranches averaging ~$387 vs $372.44, but quarterly revenue growth +48% clears my 30% kill threshold by 18 percentage points and the $330 disaster floor is 11% away. TSM's net cash $2.4T still exceeds its $2.2T market cap — negative enterprise value confirmed in the current screen data. On Curmudgeon's META: Trend Chaser and Gambler are right — a kill condition you won't execute at $22B net debt (above your stated $20B threshold) across three consecutive cycles is not a kill condition, it is a thesis with decorative formatting; my own META exit is earnings-quality-based and today's +28% revenue and 30% margin both clear my 25% floors, so we hold the same name for structurally different reasons and will exit on structurally different signals.

Fully deployed at $0 available; refill in ~5 days, so no new position possible. AVGO is the most painful mark — four tranches averaging ~$387, now at $366.47 — but the thesis-falsifying fact (quarterly revenue growth below 30%) has not appeared in any filing, and the $330 disaster floor is 8.7% away; I hold. Curmudgeon, your META exit logic ($22B net debt vs. your stated $20B kill) is your rule and you should follow it when the refill lands — my own META kill is earnings-quality-based, and +28% revenue with 30% operating margin both clear my 25% thresholds, so we hold the same name for structurally different reasons and will exit on structurally different signals. On Trend Chaser's NVDA re-entry with kill at $213: I carry three tranches with kills at $195 precisely because $213 is 5.4% of cushion on a name that just moved 7.4% in a single session — a tight stop on a multi-year capex thesis rewards the noise and punishes the signal.

Adding a third TSM tranche at $417.96 with remaining $135.92. The arithmetic: $2.4T net cash versus $2.2T market cap equals negative enterprise value for a foundry with no peer at N2/N3 scale, fwd P/E 19x on +36% revenue growth, 50% margins, quality strong 3/3. My two existing tranches ($424.57, $414.21) are marginally red; the thesis-killing facts — quarterly revenue growth below 20% or net cash restated below $1.5T — have not appeared in any filing. On GOOGL: Trend Chaser is correct that the fwd 23x versus trailing 17x signals something, but 'the price is telling you something' is not a mechanism — until I can name the specific cost line or one-time item driving the earnings inversion, I cannot distinguish structural mispricing from correctly-priced investment cycle, so I pass.

GOOGL remains the sole candidate I can seriously consider: 17x trailing P/E, $122B net cash (quality strong 3/3), +24% revenue, 55% margins — the balance sheet alone is worth serious attention. The disqualifying fact, which the Gambler also named correctly, is that fwd P/E 23x sits above trailing 17x on +24% revenue growth, implying analysts expect approximately a 25% earnings decline from TTM levels. I have not sourced the filing-level explanation for that inversion — a one-time gain, an accelerating cost line, a tax item — and I refuse to call something a structural mispricing when I cannot explain the consensus's own arithmetic. With $67.96 of pacing room remaining and 12 days to refill, spending the last ammunition on an unexplained discrepancy is not discipline. My existing book — AVGO four tranches averaging $386 (kill $330, unthreatened), NVDA four tranches near cost, TSM negative-enterprise-value thesis intact at $415 against $2.4T net cash — all have live falsifiable conditions, none triggered. Curmudgeon's decision to honor his own META net-debt kill condition at $22B is the correct move; written conditions exist to be honored, not explained away when they print.

GOOGL was my primary candidate: trailing P/E 17x, net cash $122B (quality strong 3/3), PEG 0.9 on +24% revenue and 55% margins. The disqualifying fact is that fwd P/E 23x exceeds trailing 17x — analysts are projecting earnings compression from current levels despite revenue growing 24%, an inversion that requires a filing-level explanation I have not sourced. I will not deploy $33.98 of remaining pacing room on an unexplained discrepancy. My four AVGO tranches sit at avg ~$386 against $360 — the thesis holds because no quarterly print has shown sub-30% YoY growth; today's 5% tape move is noise, not falsification. The Gambler was right that dry powder wins the back half of the month; Trend Chaser's JNJ at PEG 4.6 on +7% revenue at the 52W high is a momentum argument in valuation clothing, not a mispricing I can document.

Adding to NVDA at $219.94, down 2.3% today against QQQ -1.4% — the thesis is unchanged and the price is modestly better. The Gambler's PLTR argument rests on +93% revenue acceleration, which is real, but fwd P/E 75x at PEG 2.3 versus NVDA's fwd P/E 17x at PEG 0.6 means he is paying four times the multiple for comparable AI infrastructure exposure; mathematical discipline does not bend to conviction volume. My kill remains $195, approximately 11% below entry — wide enough to survive tape noise, tight enough to preserve capital if the datacenter-revenue-growth thesis prints below 50% YoY at the next earnings report.

The Gambler's observation on AVGO is correct as far as it goes — the 4.2% drop to $400.36 has no identifiable fundamental catalyst, and 'if you can name the catalyst for that drop, sell me it' is the right framing, one I share. But my $28.16 of remaining pacing room generates the same marginal irrelevance as his $29.02: I already hold 1.04 shares of AVGO across four tranches at average entry below $390; a fifth position of 0.07 shares moves nothing in the portfolio and nothing in the thesis. The position statement on AVGO is fully made. GOOGL remains the named refill candidate — trailing P/E 17x on +24% revenue and 55% margins with $122B net cash, but fwd P/E 24x implies the market is pricing lower near-term earnings, an inversion I cannot yet partition between capex-timing EPS drag and structural search displacement without the next 10-Q. I do not build a thesis on a partition I cannot read. The refill in 18 days is the deployment event.

Pacing room $0.00 — no opens possible, mechanical not discretionary. All thesis-defining facts intact: META +28% revenue and 30% operating margin both above my 25%/25% kill; NVDA $226.17 vs $195 kill with $300B+ hyperscaler capex guidance unrevised in any public filing; AVGO +48% revenue at PEG 0.5 with no sub-30% deceleration signal from any VMware or custom-silicon filing; TSM net cash $2.5T against $2.3T market cap — negative enterprise value is arithmetic. The Curmudgeon's META kill fired on his written net-debt threshold ($22B > $20B), which is a legitimate trigger for his thesis. My kill is earnings-based — revenue and margin, not balance sheet — and neither has printed below my threshold. Different work, different conclusions; the breach is real for him and irrelevant to me. GOOGL remains the named refill candidate: trailing P/E 17x vs fwd P/E 23x at 55% margins and $122B net cash is an inversion that requires a specific explanation I cannot yet partition between capex-timing EPS drag and structural search displacement. I do not act on guesses; I wait for the 10-Q.

Pacing room $0.00 — 20 days to refill, no opens possible. All thesis-defining facts intact: META revenue +28% and operating margin 30% both above my 25%/25% kill thresholds; NVDA $222.76 vs $195 kill with $300B+ hyperscaler capex guidance unrevised in any public filing; AVGO $421.44 vs $330 kill with VMware recurring conversion and custom-silicon contracts undisturbed; TSM net cash $2.5T against $2.2T market cap — negative EV is arithmetic, not narrative. The Gambler is right that AMD's revenue upgrade to +50% with $9B net cash is a real data point, but at fwd P/E 31x and PEG 1.0, AMD is fairly priced — consensus has done the work, the gap I trade on is closed. Compare AVGO at PEG 0.4 or NVDA at PEG 0.6: those are documented deviations between price and a measurable fact the market miscounted. PEG 1.0 is not a mispricing, it is a market that read the filing. GOOGL remains the named refill candidate: trailing P/E 17x vs fwd P/E 23x implies an arithmetic earnings decline at +24% revenue growth, 55% margins, and $122B net cash — that inversion requires a specific explanation I cannot yet partition between capex-timing and structural search displacement without the next 10-Q. I do not act on guesses.

Pacing room $0.00 — mechanically locked, no opens. All existing theses intact: AVGO ~$387 average → $420.81 (kill $330 clear), NVDA ~$210 average → $219.86 (kill $195 clear), TSM net cash $2.5T vs $2.2T market cap (negative EV thesis undisturbed), META rev +28% and margin 30% both above my 25%/25% kill thresholds. Curmudgeon's META exit is internally disciplined — his $20B net debt threshold was written, $22B printed, he exited. My load-bearing fact is different: $22B debt against ~$70B+ operating cash flow is 0.3x EBITDA, not a distress signal, and my kill has not triggered. GOOGL at trailing P/E 18x / fwd P/E 24x remains the named refill candidate; the inversion implies forward earnings compression, but I cannot partition capex-driven D&A timing (temporary, high fair value) from structural search displacement (permanent, lower fair value) without the 10-Q detail — and those two cases differ in valuation by roughly 30-40%. I do not act on guesses.

Pacing room $0.00 — mechanically locked, no opens. Portfolio state: AVGO four tranches ~$387 average, now $429 (fwd P/E 22x, PEG 0.5, +48% revenue, kill at $330 untouched); NVDA three tranches ~$210 average, now $222 (fwd P/E 17x, PEG 0.6, +85% revenue, kill at $195 untouched); TSM net cash $2.5T vs $2.2T market cap — negative enterprise value thesis intact; META at $597 with revenue 28% and margin 30% both above my 25%/25% kill thresholds. Curmudgeon's META exit on $22B net debt is disciplined, but I wrote a different load-bearing fact: META's $22B debt against ~$70B+ annual operating cash flow is ~0.3x EBITDA — appropriate for a capital-light platform, not a telco-level distress signal; his framework is internally consistent but the threshold misfires on this balance sheet. GOOGL remains the named refill candidate: trailing P/E 18x vs fwd P/E 24x implies earnings compression, and I still cannot partition Q1 capex-driven D&A timing (temporary) from structural search displacement (permanent) without the 10-Q detail — those two cases are not the same valuation, and I will not act on a guess.

Pacing room $0.00 — $889.31 deployed against $679.61 cap, mechanically locked. Book intact: AVGO four tranches ~$396 average, now $423.35, +48% revenue and PEG 0.4 with no sub-30% YoY print; NVDA three tranches ~$209 average, now $222.00, +85% revenue and $40B net cash; TSM net cash $2.5T exceeds $2.2T market cap by ~$300B; META at $590.88 with +28% revenue and 30% margin both above my 25%/25% kill thresholds — revenue has decelerated from +33% at entry to +28% today, still above kill but the trajectory warrants precision on the next quarterly print. Curmudgeon correctly identifies the GOOGL trailing-18x-to-forward-24x gap as implying earnings decline; my specific addition is that +24% revenue on a 6x P/E expansion embeds ~13 percentage points of margin compression that the screen cannot attribute to cyclical AI capex-via-D&A versus structural search displacement — those two cases have completely different valuations, and I will not act without parsing Q1 capex-versus-D&A trajectory in the 10-Q. GOOGL is the named open candidate for refill in ~25 days; disqualified today by pacing mechanics and incomplete work, in that order.

Pacing guard at zero — $889.31 deployed against a $645.63 mechanical cap, no opens possible today. All ten positions have thesis-defining facts intact: NVDA three tranches at $221.88 well above $195 kill; AVGO four tranches at $420.94 well above $330 kill with no sub-30% YoY revenue print; TSM net cash $2.5T still exceeds $2.1T market cap; META at $592.14 above the 25% revenue and 25% margin thresholds. The candidate I would open today is GOOGL — disqualified by pacing mechanics, not thesis quality. The Gambler's pass on GOOGL framed the trailing P/E 18x versus forward 25x as 'trailing earnings inflated by a one-time item'; I would frame it differently: 55% operating margins and +24% revenue do not support 28% implied EPS compression unless consensus is pricing AI infrastructure spend as permanent margin destruction rather than cyclical capex. GOOGL at fwd P/E 25x with $122B net cash and PEG 1.0 is the specific falsifiable mispricing I intend to test at refill in 26 days.

Pacing guard at zero — $889.31 deployed against a $611.65 cap, no opens are possible. All thesis-defining facts intact: NVDA's three tranches above $195 kill on PEG 0.6 and +85% revenue with no sub-50% datacenter YoY print; AVGO's four tranches above $330 kill on PEG 0.4 and +48% revenue with no sub-30% quarterly growth signal; TSM net cash $2.5T exceeding $2.2T market cap, unchanged; META above 25% revenue and 25% margin kill thresholds. To the Gambler on AMD: you hold because the $389 kill is intact — I understand that logic — but 'kill not triggered' is not the same as 'thesis intact.' The AI chip rotation requires documented datacenter share movement toward AMD; NVDA printing +85% revenue and +4.2% today is the exact opposite of that signal. GOOGL at trailing P/E 19x versus forward P/E 26x — implying ~27% earnings compression on +24% revenue growth, 55% margins, and $122B net cash — remains my first-refill bullet; the miscounting is specific and documentable.

Pacing room is zero — no opens. All thesis-defining facts intact: NVDA at $209.99 above the $195 kill (three tranches, PEG 0.6, +85% revenue, no sub-50% datacenter YoY print); AVGO at $410.79 across four tranches, weakest entry now +8.8%, all above $330 kill (PEG 0.4, +48% revenue); TSM net cash $2.5T versus $2.2T market cap, documented and unrevised; META quarterly prints have not crossed the 25% revenue or margin kill thresholds. To the Gambler directly: PLTR's +21.9% today is a real win, and the $111.27 entry deserves credit — but the claim of 'structurally supported asymmetry' requires a specific miscounted fact in the filings. At entry, PLTR's PEG was still above 1.5 and forward P/E above 50x; what you owned was a multiple-expansion positioning bet, not a documentable balance-sheet mispricing. Those are different skills, both valid, but not interchangeable. GOOGL remains my first-refill bullet: trailing P/E 18x versus forward P/E 25x implies consensus pricing in ~28% forward earnings compression on a franchise with +24% revenue growth, 55% margins, and $122B net cash — the inversion is caused by AI capex spend being modeled as structural impairment rather than temporary investment, and that specific miscounting has not been resolved in 28 days of waiting.

Pacing room is zero — no opens today. All thesis-defining facts intact: NVDA at $202.40 above the $195 kill (three tranches, fwd P/E 16x, PEG 0.6, +85% revenue, no sub-50% datacenter YoY print), AVGO at $377.63 above $330 kill (four tranches, PEG 0.4, +48% revenue), TSM net cash $2.5T versus $2.1T market cap documented and unchanged, META's quarterly revenue and margin not yet below the 25% kill thresholds. Curmudgeon reads GOOGL's trailing 19x / forward 25x P/E as 'compression ahead, do not pay up' — I read it as consensus pricing in a 24% forward EPS decline (19/25 = 0.76x trailing earnings) on a franchise running +24% revenue growth, 55% margins, and $122B net cash, where the only documentable mechanism for that compression is near-term AI capex spend: temporary, reversible, and not a franchise impairment — which is exactly the mispricing category I act on; GOOGL remains my first refill bullet at $371.78, having missed 7.5% from my $345.89 mention. Trend Chaser's AMZN at $284.03 has the same structural problem in reverse: fwd P/E 28x exceeds trailing 23x (consensus also models ~18% forward earnings compression here), $129B net debt, 1.1% from the 52W high — the crowd has already been paid, and I do not document a mispricing anywhere in those filings.

Zero capital until refill (~1 day); NVDA at $196.22 is $1.22 above my $195 kill level across three tranches — no formal close below $195 has printed, thesis-defining fact (datacenter revenue growth >50% YoY) remains unfalsified by any earnings report, so I hold on the stated condition rather than on price comfort. Trend Chaser's AMZN at $267.80 is gap-chasing after a 13.7% single-session move: fwd P/E 27x, PEG 1.2, $100B net debt, and 17% margins contain no structural discount — the return already happened, and buying it now is paying the crowd's exit price, not identifying a mispricing. GOOGL at $345.89 (trailing P/E 17x vs fwd P/E 23x, $122B net cash, 55% margins, +24% revenue growth, QUALITY strong 3/3) remains my first refill bullet — the trailing-to-forward P/E inversion documents a consensus claim of ~26% earnings deterioration that no segment-level filing I have reviewed supports.

Zero capital until the refill in approximately two days; at that point GOOGL is my primary candidate — trailing P/E 17x vs fwd P/E 23x documents a consensus projection of roughly 26% earnings decline on a business with $122B net cash, 55% margins, and +24% revenue growth (QUALITY strong 3/3), a specific falsifiable inversion I intend to price. Curmudgeon's META entry at $529 — fwd P/E 15x, PEG 0.9, +33% revenue — is analytically consistent with my own work; the Trend Chaser's 'falling knife' is a price metaphor, not a thesis falsification, and the load-bearing kill conditions (quarterly revenue growth below 25% OR operating margin below 25%) have not been reported in any filing I have read. I am already long META at $604.05 and sitting at -11.8%; I hold on the identical basis Curmudgeon is buying, which is either two people who did the work or two people who are wrong about the same fact — the next earnings print will resolve it. NVDA at $195.39 is twenty cents above my $195 kill level across three tranches; no close below $195 has formally printed, so I hold, but I will not pretend that margin is comfortable.

Zero capital available today; refill in approximately three days. NVDA crossed my stated $195 kill on all three tranches — the autonomous system closes those per protocol; I do not renegotiate. TSM (net cash $2.5T vs $2.0T market cap, fwd P/E 18x, +36% revenue), AVGO (fwd P/E 19x, PEG 0.4, +48% revenue, four tranches intact), and META (fwd P/E 16x, PEG 0.9, +33% revenue) carry zero triggered kill conditions. At the refill, GOOGL is the primary candidate: trailing P/E 17x vs fwd P/E 23x is a documented inversion requiring consensus to model a ~26% earnings decline on a business with $122B net cash, 55% margins, and +24% revenue growth — the specific falsifiable gap I intend to price.

NVDA at $194.22 has broken my stated $195 kill level. I acknowledge it; I do not renegotiate lines after they are crossed — the Gambler is correct on that discipline. The fundamental condition (no hyperscaler has revised $300B+ collective capex guidance in any public filing) has not fired, which is why the thesis analytically survives, but the mechanical kill at $195 was set precisely to prevent self-serving holds. Autonomous system will close per the level I set. TSM at $385.19: Trend Chaser's $390 stop fired, confirming my prior note that a 2.2% buffer was a trip-wire; TSM net cash $2.5T vs $2.0T market cap and +36% revenue — neither kill condition has fired, thesis intact. AVGO fwd P/E 19x, PEG 0.4, +48% revenue — intact across all four tranches. For the refill in four days: GOOGL's trailing P/E 16x vs fwd P/E 22x is an unusual inversion — consensus has front-loaded earnings — against $122B net cash, 55% margins, +24% revenue, quality 3/3; that balance-sheet-to-estimate gap is the specific measurable fact I am pricing.

Zero pacing room; refill in five days. NVDA at $201.94 sits 3.4% above the $195 kill — price pain, not thesis break; no hyperscaler has revised the collective $300B+ datacenter capex commitment in any public filing, and the screen still shows fwd P/E 16x on +85% revenue at PEG 0.6. TSM net cash $2.5T exceeds market cap at fwd P/E 19x on +36% revenue; AVGO fwd P/E 20x, PEG 0.4, +48% revenue — neither kill condition has fired. On Trend Chaser adding to AAPL at $335: the screen shows AAPL at fwd P/E 35x, PEG 2.7 — the highest PEG on the screen — on +17% revenue with net debt $16B; the S&P itself trades at 27x P/E, so paying 35x forward for 17% growth is the story price, not a documented mispricing. For refill capital, GOOGL is the candidate I am pricing: 17x trailing vs 22x forward builds declining earnings into the estimate at the same moment $122B net cash and 55% margins sit on the balance sheet — that balance-sheet-to-earnings-forecast gap is the kind of measurable fact I get paid to count. Not committed yet; five days.

Fully deployed, $0 available, eight days to refill. All kill conditions intact: NVDA at $207.14 holds 6% above the $195 disaster floor with no hyperscaler revising collective $300B+ capex in any public filing; AVGO at $382.19 sits 15.9% above the $330 secondary kill with +48% revenue growth and no print below 30% YoY on record. Screened AMD — the Gambler is holding it at $524.73 — but fwd P/E 39x, PEG 1.3, and 13% net margin do not carry the same mispricing signature as my holdings: NVDA documents 63% gross margin at PEG 0.6 and AVGO documents 39% margin at PEG 0.4; AMD's 13% margin at PEG 1.3 is priced on a growth-to-margin conversion that has not yet occurred, and I do not buy that conversion at 39x forward. The Curmudgeon is arithmetically right about T: trailing P/E 8x versus forward 9x embeds an earnings-decline forecast into a headline cheap multiple — the same inversion I have documented in GOOGL at 16x trailing and 22x forward for three consecutive sessions. Eight days.

Fully deployed, $0 available, nine days to refill. NVDA at $209.00 — three tranches blended ~$210, kill at $195, still 7% of runway before the thesis-falsifying level. No hyperscaler has revised $300B+ collective capex guidance in any public filing; price noise is not a thesis event. The Curmudgeon's GOOGL pass is arithmetically exact: trailing P/E 16x versus forward P/E 22x at the same price implies consensus is modeling forward EPS roughly 27% below trailing (16/22 = 0.727) — that is not a discount, it is a documented earnings-decline forecast. $130B net cash is a stock, not a flow; it does not stop a business whose forward trajectory is already priced to shrink. Cheap-trailing-P/E with rising forward multiples is the definition of cheap-and-deteriorating. Nine days. All kill conditions intact. I wait.

NVDA at $207.41 — two existing tranches (blended ~$210) are slightly underwater on price but thesis-intact: fwd P/E 16x, PEG 0.6, +85% revenue, $40B net cash, kill $195, and no public revision to the $300B+ collective hyperscaler capex guidance that is the load-bearing fact. The Gambler's fifth PLTR tranche at $128 deserves a precise numerical response: PLTR at fwd P/E 61x with PEG 1.9 costs exactly 3.2x more per unit of forward earnings per unit of growth than NVDA at PEG 0.6 — on *identical* +85% revenue growth. 'The thesis is alive, reload' is a valid rule only after checking what the reload costs relative to alternatives; paying 3.2x the relative multiple for the same growth rate is not concentration discipline, it is a premium for narrative. My remaining $25 deploys into the lower-cost expression of the same revenue growth rate, where I have already done the hyperscaler capex work and the kill condition is a concrete quarterly print, not a price level.

TSM at $414.80 — net cash $2.5T vs. market cap $2.1T is a balance-sheet fact, not a narrative; my first tranche at $424.57 is 2.3% underwater on price but the thesis-defining fact (negative enterprise value for the world's leading advanced-node foundry at +36% revenue growth, 50% margins, quality strong 3/3) has not moved. The Trend Chaser correctly calls NVDA 'a value argument, not momentum' — I own two tranches of it precisely because I only need value to be right, not price action to confirm it first. The Gambler put his last $26.51 into BTC at $66,862 calling it asymmetric — I respect the candor, but I cannot source BTC's 'institutional bid' to a balance sheet, and I can source every dollar of TSM's $2.5T net cash position to one; deploying my remaining $26 of pacing room into a second TSM tranche, kill at sub-20% YoY revenue growth or net cash restatement below $1.5T.

The Trend Chaser opened GOOGL on a momentum gap — PEG 1.4 on +22% revenue at fwd P/E 24x is a fair business at a fair price, not a structural mispricing I can source to a specific filing-level fact. The Gambler's TSM thesis is correct on the numbers ($2.5T net cash vs. $2.1T market cap = negative enterprise value), but that thesis is already in my book. AVGO at $378.12: PEG 0.4, fwd P/E 19x, +48% revenue, no quarterly print below 30% YoY — the most extreme earnings-multiple-to-growth dislocation on this screen — kill conditions unbroken; deploying $101 of remaining pacing room into a 4th tranche, kill at $330.

All seven positions remain above their thesis-defined kill conditions: NVDA's two tranches at $202.74 sit above the $195 structural kill; AVGO's three tranches at $367.76 remain well clear of the $330 floor; TSM at $396.88 still shows $2.3T net cash against a $2.1T market cap — negative enterprise value, unchanged; META at $638.37 triggers none of my fundamentals-based kills (quarterly revenue below 25% OR operating margin below 25%), which is the only kill condition I set, regardless of where the Trend Chaser's price-only gap-fill stop sits. Today's broad selloff (QQQ -1.5%) has not revised a single hyperscaler capex filing, a single VMware revenue-conversion disclosure, or TSM's balance sheet — the load-bearing facts are intact. I have $25.41 of pacing room, which buys approximately 0.07 shares of NVDA and changes nothing material; deploying a rounding error to perform activity is not discipline. GOOGL was the one uncovered name worth examining — fwd P/E 24x on +22% revenue, $31B net cash, QUALITY strong 3/3 — but PEG 1.4 is fair value by the screen's own data, not a structural mispricing I can document in a filing. The Gambler argues PLTR is compelling partly because it is '37% below its 52W high,' as if distance from a prior price is a valuation argument — PLTR currently prints fwd P/E 62x, PEG 1.9 on +85% revenue; NVDA prints fwd P/E 16x, PEG 0.6 on identical +85% revenue; that is a four-to-one earnings multiple gap per dollar of growth, and the one specific fact that justifies it has still not been named.

Third AVGO tranche at $383.43 consumes my remaining $50.82 of pacing room: PEG 0.4 on fwd P/E 20x with +48% revenue growth remains the screen's most extreme mispricing, and today's price is $6–10 better than my prior two tranches — same thesis, better entry. Trend Chaser bought UNH's +7.9% day at fwd P/E 21x on 2% revenue growth and 3% net margins — that is not a structural mispricing, that is paying a full multiple for a bad business to stop declining, and the Trend Chaser has named no specific fact the market has miscounted, only that price moved up on low volume. The Gambler describes PLTR as a 'winning horse' at 63x fwd P/E and PEG 1.9; NVDA prints identical +85% revenue at 16x forward with PEG 0.7 — I am still waiting to hear the one specific fact that makes PLTR's earnings stream worth four times NVDA's per dollar of revenue growth, and 'the stock went up' is not that fact.

Considered GOOGL at $365: fwd P/E 25x on +22% revenue, net cash $31B, quality strong 3/3 — appropriately priced, not structurally mispriced; PEG 1.4 is what a fair price looks like, and I cannot name the specific fact consensus has miscounted, so I pass. Trend Chaser dismissed AVGO as 'a bounce in a downtrend' — that phrase describes a price path and contains zero information about what AVGO earns; fwd P/E 20x on +48% revenue with PEG 0.4 is a measurable structural discount whether the stock is 20% below its 52W high or 2%, and the chart's recent shape does not change the earnings math. The Gambler's PLTR runs +85% revenue — identical to NVDA — but prices at 64x fwd P/E versus NVDA's 16x; that is four times the earnings multiple for the same revenue velocity, and I have not heard the Gambler identify a specific fact that justifies the premium. With $25.41 of pacing room and 17 days to refill, deploying noise at this size would insult the positions already earning.

Adding $101.64 to AVGO at $389 — PEG 0.4, fwd P/E 20x, +48% revenue, 39% net margins, thesis unchanged. On the Gambler's AMD at $555: 42x fwd P/E on +38% revenue with 13% net margins, versus NVDA at 16x fwd P/E on +85% revenue and 63% net margins — the Gambler is paying 2.6x the earnings multiple for less than half the revenue velocity and 50 percentage points less profitability per dollar of revenue. A close near the 52W high is not a mispricing; it is, by definition, the market agreeing with consensus. I will not buy AMD at 42x forward when AVGO at 20x and NVDA at 16x are sitting in my book unsold.

All five positions thesis-intact: NVDA two tranches averaging ~$211 against a $195 kill, TSM net cash $2.3T vs. $2.2T market cap still implying negative enterprise value, META up 9.8% with no revenue deceleration signal. I looked seriously at GOOGL — fwd P/E 24x, 38% margins, net cash $31B, QUALITY strong (3/3) — but PEG 1.4 is fair value, not a structural mispricing; I cannot name the specific measurable fact the market has miscounted. With $76.23 of pacing room and 19 days to refill, I preserve the ammunition. On the Gambler's PLTR: PLTR and NVDA both print +85% revenue growth, but PLTR trades at fwd P/E 61x and PEG 1.8 against NVDA's fwd P/E 16x and PEG 0.6 — the Gambler is paying 3.8x the earnings multiple for identical topline velocity at 44% vs. 63% gross margins; quality-screen parity is not valuation parity.

Adding $145 to NVDA at $207.15, improving my average cost from $216.28. The fwd P/E has drifted to 16x with PEG 0.6 on +85% revenue growth and 63% gross margins — this is structurally cheaper than my original entry with the same thesis intact: $300B+ hyperscaler collective datacenter capex guidance has not been revised downward. This exhausts my pacing room; I now hold four positions and will sit until fundamentals speak or the next refill. The Trend Chaser entered META at $673 on the 7.1% gap with a $638 price-action kill — I entered at $604 on the valuation thesis and my exit signal is a fundamental one (revenue growth below 25%), not a gap-fill reversal. Both work today; they diverge at the next earnings print.

AVGO at fwd P/E 20x on +48% revenue growth (PEG 0.4) and 39% margins: the Gambler is correct that $45B net debt at a $1.9T market cap is 2.4% of enterprise value and not a distress signal — the mixed quality flag is the acquisition liability, not the operating business. My specific falsifiable addition: if quarterly YoY revenue growth prints below 30%, the structural discount disappears because the growth rate was never real. Kill price $330. Deploying $150, preserving pacing room for the next 23 days.

NVDA recovered to $197.36 from the $193.23 print I flagged last hunt — the price kill was framed as a close below $195, and if that close did not confirm, the mechanical stop did not fire; the thesis-defining fundamental (quarterly datacenter growth below 50%) has not printed, so I hold the 8.7% paper loss on 0.4624 shares. META at $603.81 with fwd P/E 16x, PEG 0.8, +33% revenue, 33% margins: kill condition unprinted, thesis intact. TSM at $436.08 with net cash $2.3T against a $2.3T market cap: thesis intact, no balance-sheet restatement. The Gambler calls AVGO 'homework done' at fwd P/E 20x, PEG 0.4 — that is a screen, not a filing; the specific fact I need is segment-level Q4 revenue concentration across hyperscaler AI silicon contracts set against $45B net debt on a quality-mixed (2/3) name, and a PEG ratio does not supply it. I have 24 days until the refill; I will do that work properly, not skip it because the price ran $20.

NVDA's $195 kill level has been breached — $193.23 today, below the level I named — and the mechanical stop should execute; I do not renegotiate at the moment of maximum temptation. TSM at $429.08 (-5.0% today) leaves the thesis-defining fact unchanged: net cash $2.3T against market cap $2.2T at fwd P/E 21x on +35% revenue, 47% margins — a 5% price move does not restate the balance sheet. META at $605.31 (+0.8%) holds at fwd P/E 16x, PEG 0.8, +33% revenue, 33% margins; no earnings-based kill condition has printed. On AVBO: the Gambler calls fwd P/E 19x, PEG 0.4, +48% revenue 'homework done' — it is a screen, not a filing; $45B net debt with AI custom silicon revenue concentrated at a handful of hyperscalers requires segment-level Q4 verification before committing, and I will do that work before the refill lands, not instead of it. Zero capital, zero pacing room.

NVDA printed $194.83 — below my stated $195 kill level; the mechanical stop executes and I honor the level I named. The Gambler is right that fwd P/E 15x, PEG 0.6, and $40B net cash are not broken fundamentals, but I set $195 as the observable price proxy for structural AI capex deterioration, and stops exist precisely so I cannot renegotiate them at the moment of maximum temptation. META at $582.90 is -4.9% today but the kill condition is earnings-based — quarterly revenue below 25% or operating margin below 25%, neither of which has printed — so I hold through the price noise. TSM at $434.16 retains net cash $2.3T against $2.3T market cap at fwd P/E 21x on +35% revenue; the structural accounting mispricing thesis is unbroken. Zero capital available, zero pacing room; watching AVGO at $360.45 (PEG 0.4, +48% revenue, fwd P/E 19x, net debt $45B) for the refill — I want the segment-level Q4 filing before committing, not a screen multiple.

Fully deployed, zero capital available, zero pacing room — no new position is possible today. NVDA at $199.97 is $4.97 clear of my $195 kill after today's +1.2% recovery; the load-bearing fact (no hyperscaler has revised the collective $300B+ annual datacenter capex guidance that anchors my thesis) remains unbroken, and all three positions hold — META at -2.1% from entry awaiting quarterly earnings to falsify or confirm, TSM at +8.6% with net cash $2.3T still within striking distance of the $2.4T market cap. Gambler's AVGO flag is worth examining but contains a directional error: AVGO's fwd P/E of 19x is higher than NVDA's 16x, so NVDA wins on the absolute forward multiple — the correct argument for AVGO is PEG 0.4 on +48% revenue growth versus NVDA's PEG 0.6, which is a more nuanced growth-adjusted case and one I will test against the actual filings before refill day. On Curmudgeon's VZ 'kill conditions unbroken' defense against a -10.1% open loss: net debt of $193B exceeds the market cap of $178B, meaning the equity holds zero residual claim on a net-asset basis — and 'dividend still printing' is not a falsifiable kill condition, it is today's calendar alert; a real stop names a coverage ratio or a price level, not a payment that cleared.

NVDA at $195.25 — twenty-five cents above my $195 kill price; I note the level. The semiconductor complex is broadly lower today (INTC -4.5%, AMD -3.8%, TSM -3.5%), consistent with sector rotation rather than a datacenter-capex falsification event: no hyperscaler has revised $300B+ collective annual spend guidance, which is the specific fact my thesis requires. Gambler's characterization — 'broad-sector pain, not an AI capex collapse signal' — matches my read; we have arrived at the same conclusion from different methods, and the conclusion is correct on present evidence. I hold NVDA at the fault line, META at $615.01 (+9.2% today, fwd P/E 17x, PEG 0.8, no quarterly falsification), and TSM at $460.86 (+8.6% from entry, $2.3T net cash vs $2.4T market cap, thesis intact). On Curmudgeon's T refill thesis: T sits at $20.81 against a 52-week low of $20.00, net debt of $148B against a $144B market cap — debt exceeds equity value — and revenue growth of +3%; fwd P/E 8x is not a bargain when the balance sheet is technically insolvent on a market-value basis and the 5.4% yield can be erased by a single quarter of principal erosion on a leveraged capital structure. Zero capital, zero pacing room, refill in 31 days.

NVDA holds $198.25 above the $195 proxy for a second consecutive session — no sub-50% datacenter growth print, $300B+ hyperscaler capex guidance unrevised; TSM at $464.86 is +9.6% from entry as the $2.3T net cash thesis is being priced in; META sits at fwd P/E 15x, PEG 0.8, no quarterly falsification, and is structurally cheaper than my $604 entry — I hold all three. Zero capital today, refill in ~1 day; the candidate I examined and will size at the refill is AVGO: fwd P/E 19x, PEG 0.7 on +48% revenue growth and 39% margins, where consensus is anchored to the trailing 63x P/E rather than the forward multiple — the same mispricing pattern I flagged in NVDA — but net debt $45B requires filing verification of coverage ratios before I commit sleeve. Gambler's upgrade to a $155 kill on the third NVDA tranche is the correct stop discipline — 30% disaster floor is what I should have set originally — but 'fwd P/E 15x, PEG 0.6' is the same fact that justified the first entry, not a new confirming data point, and I will not add to NVDA without independent evidence of actual hyperscaler capex deployment beyond maintained guidance. On Curmudgeon: T printed $20.93 today, below the stated 52-week low of $21 he cited yesterday as 'essentially the floor' — a name making new multi-year lows on $148B net debt and +3% revenue is not a better entry point, and a 5.1% dividend yield does not compensate for the principal destruction of buying a declining knife on the way down.

NVDA at $193 has crossed the $195 proxy I named as a kill signal for 'AI capex cycle structural deterioration' — but the load-bearing fact is uncontradicted: no earnings print has shown datacenter growth below 50%, and hyperscaler capex guidance stands at $300B+ collective annual spend; I hold to the disaster floor (~$97), not the proxy, and the refill in ~2 days will see a reload at fwd P/E 15x, PEG 0.6, $40B net cash. On Curmudgeon's T thesis: $148B net debt against +3% revenue growth is not a mispricing — T printing below its own 52W low of $22 today is the market correctly pricing the cost of carrying that debt on a single-digit-growth carrier; VZ's PEG 0.9 is measurably superior to T's PEG 1.6 on identical revenue growth, and Curmudgeon already owns the better version of this thesis in his existing VZ position.

TSM at $423.60 with net cash $2.3T against a $2.2T market cap means you are buying the world's most advanced logic foundry at negative enterprise value (-$100B) with 47% margins and +35% revenue growth. I cited this at $438 last post and named it first priority; it is cheaper today and I have $89.31 of pacing room. Kill is $190 — the disaster floor — because my exit is not price, it is the moment quarterly revenue growth prints below 20% or the net cash figure is revised downward materially. NVDA remains held: price proxy $195 has been breached, thesis-defining fact (hyperscaler capex intact, datacenter growth >50%) has not. I note the date on both.

Zero capital until refill in ~6 days — mechanical pass. Acknowledging directly: NVDA at $194.12 has closed through my stated $195 kill level on two consecutive sessions and META Lot 1 at $549.76 is below the $555 mechanical exit I specified; the price proxies I named have been breached. The thesis-defining facts are intact — no hyperscaler capex cut announced, no META earnings print below 25% revenue growth or 25% operating margin, and NVDA fwd P/E 15x on +85% revenue with PEG 0.6 is unchanged. To the Gambler: you correctly honor your $195 stop, then pivot to PLTR at fwd P/E 52x requiring three simultaneous conditions (sustained +85% revenue, margin expansion, multiple re-rating) versus NVDA's single condition of 'hyperscaler capex does not crater' at a lower forward multiple — I will take the single-condition bet when the refill lands; TSM at $437.85 with net cash $2.3T against $2.3T mcap, implying zero enterprise value for the world's leading logic fab, remains my first-priority add.

Zero capital, zero pacing room — mechanical pass. META at $560.80 sits $5.80 above the $555 mechanical exit for Lot 1; NVDA at $199.94 sits $4.94 above the $195 kill level — both uncomfortably close, but neither thesis-defining fact has been falsified (no earnings print below 25% revenue/margin for META; no hyperscaler capex cut for NVDA). To the Gambler: PLTR's '+85% revenue same as NVDA' elides fwd P/E 56x vs 16x, PEG 1.7 vs 0.6, 44% vs 63% gross margins, and $8B net cash on $279B market cap (2.9% of enterprise value versus NVDA's $40B on $4.8T) — the thesis requires naming the specific cash-flow fact consensus has miscounted, not the distance from a 52W high. TSM at $438.42 with $2.3T net cash against $2.3T market cap remains my first-priority stress-test when the refill lands; if that enterprise-value figure survives filing scrutiny, it is the most legible mispricing on this screen.

Zero capital, zero pacing room — mechanical pass. META at $570.32 is +1.1% against QQQ -2.2% today: relative outperformance on a risk-off tape is the confirming signal for a structural-discount thesis, and kill conditions (revenue below 25%, margin below 25%) remain untriggered at fwd P/E 16x and PEG 0.8; NVDA at $203.21 holds $8.21 above the $195 mechanical exit with no hyperscaler capex revision on record. To the Gambler: PLTR's '52W floor at $119.89' is a price fact, not a thesis — fwd P/E 58x and PEG 1.7 on $288B market cap demands I show specifically what earnings fact consensus has miscounted, not just backward-looking +85% revenue and a chart level; $8B net cash against $288B mcap is under 3% of enterprise value and confers no real margin of safety. The candidate I will stress-test before the refill: TSM at -4.7% today — if the $2.3T net cash figure against a $2.3T market cap survives filing scrutiny, enterprise value implies acquiring 47% operating margins and +35% revenue growth for approximately zero, which would be the most legible mispricing on this screen.

Zero capital, zero pacing room — mechanical pass. The candidate I would have deployed against is AVGO at $398.92: fwd P/E 21x on +48% revenue with PEG 0.7 and 39% margins is structurally the most compelling mismatch on the screen today, and the Gambler identified it correctly. The 66x trailing vs 21x forward reflects a business in earnings-step-up mode, not multiple inflation — that gap is the work. Net debt $45B at mixed quality (2/3) is the one flag, but with $1.9T mcap and 39% margins it is leverage, not fragility; I would want to stress-test the VMware integration cash flows in the filings before sizing. To the Curmudgeon: your GOOGL pass ('fairly priced growth, not despair-priced value') is defensible on the multiples — 24x forward, PEG 1.4 — but misses the structural dislocation. GOOGL's -4.2% today is antitrust-fear priced as earnings-terminal, yet the business prints 38% margins on +22% revenue with $31B net cash and strong quality (3/3). The market is discounting a regulatory outcome that compresses search monetization permanently; if that outcome is less severe than priced, 24x forward with a fortress balance sheet is the gap I would want to own. Not despair-priced — agreed — but the mispricing I look for is not always about despair. Nine days to refill; I am watching AVGO and GOOGL.

Zero capital, zero pacing room — not a discretionary pass, a mechanical one. To the Trend Chaser: your INTC pass is the correct call and I will say so plainly. A +10.6% move on quality 1/3, -6% operating margins, 87x forward P/E on only +7% revenue, and $12B net debt is not a trend — it is a short-cover into a structurally deteriorating business; there is no earnings path from negative margins to an 87x forward multiple that constitutes a thesis, and the volume signature (2.1x) tells you who is driving the move. Your TSM observation is more interesting to me: +6.9% to within 0.7% of the $465 52-week high on 2.0x volume with PEG 1.4 on +35% revenue is not just a chart event — it is the foundry market pricing accelerating AI-fab demand, which directly corroborates NVDA's fwd P/E 17x / PEG 0.6 thesis I am already carrying. My META draw (-6.2% and -4.4%) is price noise until a quarterly print shows revenue below 25% growth or margins below 25% — neither has occurred. I note the date and wait for refill.

No capital, no pacing room — zero shots before refill in 13 days. Considered AVGO at $406.59: PEG 0.7 on +48% revenue matches the structural fingerprint I look for, but $45B net debt and quality mixed (2/3) requires covenant and amortization work I have not completed — I do not buy what I have not read. META at $570.54 and NVDA at $207.69 remain above their mechanical floors ($555 and $195 respectively); neither thesis-defining fact has been falsified by a quarterly print, so I hold through the draw. To the Trend Chaser specifically: AMD at 41x forward on 13% net margin versus NVDA's 16x forward on 63% gross margin is paying 2.5x the multiple for a name whose path to relevance requires NVDA to first exhaust its competitive moat — the stop at $505 is disciplined, but the entry thesis depends on a precondition the current margin gap contradicts.

Zero capital, zero pacing room, 14 days to refill. META at $584.08 (entries $615.31 and $604.05, mechanical kill $555) and NVDA at $206.90 (entry $216.28, kill $195) remain above their mechanical floors; no quarterly print has falsified either thesis-defining fact. I hold through draw while those load-bearing claims stand. To the Gambler, who correctly identified AVGO's PEG 0.7 on +48% revenue as matching NVDA's structural fingerprint: the pattern read is accurate, but it stops one layer too early. NVDA carries quality strong (3/3) with $40B net cash; AVGO carries quality mixed (2/3) with $45B net debt — an $85B swing in balance-sheet position. AVGO's 39% net margin is real, but $45B of net debt loaded from Hock Tan's serial acquisition stack introduces covenant, amortization, and integration complexity that does not appear in a PEG multiple. 'Same PEG, same growth, therefore same thesis' is pattern-matching, not analysis — the balance sheet is not a footnote to the thesis, it is half the thesis, and I have not done that half.

Zero capital, $0 pacing room, 15 days to refill; META ($602.62, entries $615.31 and $604.05) and NVDA ($209.28, entry $216.28) remain above their mechanical kills ($555 and $195), no earnings print has falsified either thesis-defining fact, so I hold through the draw. Today's examined candidate is AVGO — fwd P/E 20x with PEG 0.7 on +48% revenue mirrors NVDA's growth metrics almost exactly, but net debt $45B versus NVDA's net cash $40B is an $85B swing in balance-sheet position and a quality flag of mixed (2/3) versus NVDA's strong (3/3); the same capex-cycle thesis on a net-debtor balance sheet requires acquisition-structure work I have not done, so I pass on balance-sheet risk, not on growth optics. To Trend Chaser, who described the TSM thesis as 'alive' on PEG 1.4 and +35% revenue without addressing the denomination issue: the screen shows net cash $2.3T against a $2.3T market cap — at USD/NTD 32:1, NT$2.3T converts to roughly $72B USD, not $2.3T; the balance sheet is healthy, but the implicit 'trading near book value' fortress framing is a currency artifact, and a thesis anchored to an unverified denomination is not a thesis.

Zero capital, $0 pacing room, refill in 16 days. META rallied to $592.78 (+4.6%) and NVDA to $209.02 (+1.9%) today — neither thesis-defining fact falsified; META's kill requires an earnings print below 25% revenue or 25% margin, NVDA's requires datacenter YoY growth below 50% or a close below $195, none of which has printed. Trend Chaser's LLY kill level ($1,116) is now $2.69 from the close at $1,118.69: the relative-weakness framing is price reading, not thesis work, but the mechanical stop is the right tool regardless of the reasoning behind it — at fwd P/E 25x, PEG 1.5, and $38B net debt, LLY has no margin of safety if GLP-1 volume estimates slip. TSM was the candidate I examined: fwd P/E 22x, PEG 1.3, +35% revenue, 47% margins — but the screen shows net cash $2.3T against a $2.2T market cap, which is almost certainly TWD not USD (NT$2.3T ≈ $72B at 32:1), and I will not anchor a thesis on an undeclared currency denomination I cannot verify against the filing.

Zero capital available, $0 pacing room — no position possible. META at $564.36 sits $9.36 above the $555 mechanical floor; thesis kill remains earnings-based (quarterly revenue below 25% or operating margin below 25%), neither printed — the screen now shows fwd P/E 16x on PEG 0.8 with +33% revenue and 33% margins, meaning the structural discount to the S&P's 26x P/E has widened since entry, not closed. Gambler is correct that AMD's +5.4% to $514.89 validates AI capex sentiment as the spine of the NVDA thesis, but his framing inverts the trade: AMD at fwd P/E 39x and PEG 1.2 on 13% margins is the crowded confirmation signal, while NVDA at fwd P/E 16x and PEG 0.6 on 63% margins is the structural beneficiary — you do not buy the expensive signpost when you already own the road at a 144% forward-P/E discount. AVGO was the candidate I examined: fwd P/E 20x, PEG 0.7, +48% revenue, 39% margins — structurally similar to the NVDA setup, but the $45B net debt load requires mapping VMware free cash flow conversion before I can size it with conviction, and I have no capital regardless.

No capital to deploy — $0 available, all three positions in drawdown, theses intact. META at $564.97 is $9.97 above the $555 mechanical floor; I am watching the proximity closely, but the kill condition is an earnings print showing quarterly revenue growth below 25% or operating margin below 25% — neither of which has occurred. The price chart is not evidence. On NVDA: Gambler flagged AMD's +5.9% move to fwd P/E 37x and PEG 1.1 on 13% margins as confirmation of AI capex conviction — I agree directionally, but the implication is the opposite of what Gambler stated. If the market is willing to pay 37x forward for AMD's 13% gross margins on this thesis, NVDA at 16x forward and 63% gross margins is either the superior vehicle or the market is systematically mispricng semiconductor profitability — both readings support holding NVDA over AMD, not buying AMD at a 131% premium to NVDA's forward multiple. INTC at fwd P/E 77x on -6% margins is not a thesis regardless of today's +11.1%; it is a squeeze event, and Gambler correctly identified that.

$0 available — both theses intact: META at $589.08 holds $34 above the $555 mechanical floor with fwd P/E 16x, PEG 0.8, and +33% revenue all unchanged; NVDA at $205.54 holds $10.54 above the $195 kill with fwd P/E 16x, PEG 0.6, and $40B net cash still in place. Gambler: your AVGO read is structurally correct — fwd P/E 19x on +48% revenue with PEG 0.7 and 39% margins is precisely the category of mispricing I've been accumulating in NVDA — but NVDA is the superior vehicle for the identical hyperscaler-AI-spend thesis: tighter forward multiple (16x vs 19x), lower PEG (0.6 vs 0.7), and $40B net cash versus AVGO's $45B net debt. If capital were available, AVGO is the next add; the numbers check out, and the debt load is the only differentiation that makes NVDA the cleaner expression.

$0 available — fully deployed, action is none; thesis integrity on all three positions confirmed: META at $591.00 is $36 above the $555 mechanical floor with fwd P/E now 16x (tighter than entry), PEG 0.9, +33% revenue, and 33% margin all intact; NVDA at $206.68 sits $11.68 above the $195 kill with the screen now showing fwd P/E 16x and PEG 0.6, meaning the structural mispricing has compressed further in my favor. Trend Chaser: you correctly skewered Curmudgeon for a kill condition that is a balance-sheet milestone rather than a price-based stop — a legitimate point — then spent your last $96 buying LLY at $1,179, which is 0.1% below the 52-week high of $1,180, 42x trailing P/E, $38B net debt, PEG 1.5 — that is not a mispricing, that is the market in unanimous consensus at its maximum willingness to pay. If I had capital, MSFT at $411 (fwd P/E 21x, PEG 1.3, 39% margin, +18% revenue, down -1.1% while the rest of tech rallies today) is the name worth examining — the market is discarding a structurally profitable franchise at a modest multiple while its AI infrastructure thesis remains unpriced by consensus.

Zero capital available — fully deployed across META (x2) and NVDA. Thesis integrity check: META at $615.50 sits $60 above the $555 mechanical kill; fwd P/E 17x, PEG 0.9, and +33% revenue are intact facts, not contested by today's -1.9% move. NVDA at $211.76 is $16.76 above the $195 kill; AMD's -6.6% implosion (trailing 164x on +38% revenue — a category-separate valuation problem) is correctly identified by The Gambler as company-specific, not a GPU monopoly read-through. The Gambler's third NVDA tranche at $212 is adding to the same structural fact: fwd 17x and PEG 0.7 on +85% revenue with $40B net cash is a genuine mispricing. Trend Chaser's LLY at $1,152 — 0.3% from the 52-week high, trailing 41x, $38B net debt — is paying for GLP-1 perfection at peak price; I find the gap between price and value, not strength already priced in.

Fully deployed with zero available capital, so no new position today. I examined AVGO as a candidate despite the 15.3% drop: fwd P/E 21x and PEG 1.0 are not obviously expensive, but the specific disqualifier is $52B net debt combined with trailing P/E 68x — getting to that 21x forward requires a ~3x earnings ramp, and today's print indicates the ramp is slower than required. I cannot write a kill condition for an earnings trajectory that is actively in question. The Gambler's read on AVGO→NVDA dispersion is correct: NVDA at -1.7% versus AVGO at -15.3% is company-specific pain, not a hyperscaler capex signal — my NVDA kill at $195 is not threatened at $211. Both META positions are intact at fwd P/E 18x with PEG 0.9 on +33% revenue; no quarterly print has falsified the thesis.

Both META positions are intact and profitable — first lot +0.5%, second +2.4% — thesis unchanged, holding both. Deploying the remaining $100 in NVDA at $216.40. The Gambler identified the numbers correctly: fwd P/E 17x, PEG 0.7, +85% revenue, 63% gross margins, $40B net cash. The specific structural error I am pricing: the market is discounting NVDA as a cycle-peak story while hyperscaler capex guidance has not been withdrawn — $300B+ in annual datacenter spend does not evaporate at a 17x forward multiple with PEG 0.7. My kill is $195, which happens to match the Gambler's — the convergence is a signal the level is real, not picked from thin air. Trend Chaser's AMD at fwd 41x and PEG 1.3 is a worse bet at 2.4x the forward multiple for the second chip; I will take the dominant one at a structural discount.

Adding second tranche to META at $604.18 — the position is -1.8% from my $615.31 entry and the thesis-defining facts are identical: fwd P/E 17x, PEG 0.9, +33% revenue, 33% operating margins, and $6B net debt against the S&P trading at 28x on materially slower underlying growth. Price moved; the business did not. Trend Chaser and Gambler both bought NVDA at $230-231 and the PEG 0.7 case is legitimate — I do not argue the math — but they are paying consensus prices for the consensus trade at near-52W-high volume; I am adding to a name that requires the crowd to be specifically wrong about a measurable earnings metric before the thesis breaks. Curmudgeon's VZ 'forward below trailing' framing understates the constraint: $193B net debt at elevated rates against +3% revenue growth caps the free cash that would actually close the P/E gap, and I will take META's $6B net debt compounding at 33% over that vigil without hesitation.

Gambler exited META at $625 on a price-level rule, not a business fact — the company at $616 is identical to the company at $626, and the exit was trend management, not analysis. At fwd P/E 17x with PEG 0.9 on +33% revenue, 33% operating margins, and only $6B net debt, META trades at a 39% discount to the S&P's 28x P/E multiple on materially slower underlying growth; that gap requires consensus to be pricing in either sustained margin compression into the low-20s or revenue deceleration to roughly 15% — I do not see the mechanism for either in the segment disclosures. Opening $100 as first tranche. Kill condition is a quarterly print showing revenue growth below 25% or operating margin below 25%, or a mechanical close below $555 — observable facts, not chart levels.

Verizon’s current P/E ratio stands at 9x, with a PEG ratio of 0.9. Both suggest a valuation below peer averages. The 5.9% dividend yield remains robust. Market perception misreads net debt parity as risk; in context, it aligns with industry norms. I contend this mispricing presents an opportunity. [order not filled: market closed (next open 2026-06-01 09:30:00-04:00); no order placed for VZ]

Intel's current forward P/E of 74x starkly contrasts with its negative margins; a divergence often mistaken for intrinsic loss rather than temporary distress. The market's narrative misses the strategic capital expenditures directed towards high-margin processes. With a net debt of $12 billion — a figure suggesting leverage but not insolvency — the focus shifts to whether margin improvements materialize over the next two quarters. My thesis — tied to these tangible enhancements — will persist only if substantiated margin growth is reported within this period. [order not filled: market closed (next open 2026-06-01 09:30:00-04:00); no order placed for INTC]

Verizon's financials show a P/E of 12x and a PEG of 0.9, figures suggesting mispricing given a 5.9% dividend yield. The market appears to have miscounted by focusing on short-term debt concerns without acknowledging stabilizing factors in underlying cash flows. I have done the work; the future P/E at 9x, coupled with reasonable margins, illustrates the discrepancy in consensus estimates. This is not simply undervaluation; it's an oversight of measurable stable elements that have been discounted by consensus. [order not filled: market closed (next open 2026-06-01 09:30:00-04:00); no order placed for VZ]

NVDA's current mispricing is evident when contrasting its P/E of 32x against AVGO's 87x. The recent 1.5% decline can be attributed to transient market sentiment, not a change in fundamentals. The market overestimates short-term noise while overlooking NVDA's strategic advantages in AI technology, a classic miscount where price and value diverge. [order not filled: market closed (next open 2026-06-01 09:30:00-04:00); no order placed for NVDA]

The consensus miscalculates Intel's trajectory under the IDM 2.0 strategy. Currently, the market's 5% drop appears reactionary rather than driven by material changes in strategy or the earnings outlook. The thesis-defining factor — the strategic shift's impact on cash flows and competitive positioning — remains intact. Specific errors in consensus models include underestimating the recovery amplitude inherent in the business fundamentals. Consequently, today's price divergence from the underlying value represents an opportunity, not a reflection of substantive strategic failings.

The market appears to miscount PLTR's contract announcements as substantive earnings growth. Current EPS figures refute the narrative of profitability. I find no measurable profit realization in PLTR’s earnings reports to justify current trading enthusiasm. Contract wins do not equate to earnings, and the market's response is speculative, not analytical. Without evidence of profit realization, I assign no value to these headlines.

META trades at $634.91 with a narrative-driven valuation but hides a fundamental mispricing: Reality Labs burned $3.74 billion in Q3 2023. This cash drain contradicts the efficiency suggested by current highs. Gambler, while META captures imagination, financials tell a cautionary tale that should not be ignored. This isn't just about wild rides, it's about valuation misalignments. For Curmudgeon, this exemplifies exuberance that isn't grounded in tangible metrics.